Standardising and Simplifying the Global Leadership Initiative on Malnutrition (GLIM) for Its More General Application
1 other identifier
observational
300
1 country
1
Brief Summary
This observational study of aims to test whether and how the results of GLIM change when using different approaches and methods to carry out its components.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 1, 2023
CompletedFirst Posted
Study publicly available on registry
December 11, 2023
CompletedStudy Start
First participant enrolled
December 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedMarch 28, 2025
February 1, 2025
1.3 years
November 1, 2023
March 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Subjective Global Assessment (SGA) defined malnutrition
Subjective Global Assessment (SGA) can be considered a method that is close to a "gold standard" for malnutrition assessment. Therefore, the study will analyse how different approaches to screening and muscle mass measurement affect the performance of GLIM in detecting Subjective Global Assessment (SGA) defined malnutrition.
baseline, pre-intervention/procedure/surgery
One-year mortality
One year after the data collection, we will look at the patient records to collect the 1-year mortality data. This will give information about whether and how different approaches to components of GLIM affect its ability to predict one-year mortality.
through study completion, an average of 1 year
Computed tomography (CT) defined muscle mass
One of the GLIM criteria is "reduced muscle mass", and this study will investigate how muscle mass measured with simpler methods compares against muscle mass measured with CT.
baseline, pre-intervention/procedure/surgery
DEXA defined muscle mass
One of the GLIM criteria is "reduced muscle mass", and this study will investigate how muscle mass measured with simpler methods compares against muscle mass measured with DEXA.
baseline, pre-intervention/procedure/surgery
Secondary Outcomes (1)
Bioelectrical impedance (BIA) defined muscle mass
baseline, pre-intervention/procedure/surgery
Study Arms (1)
Inpatients of the Tartu University Hospital
Inclusion Criteria: Age of 18+ years, able and willing to sign the consent form, inpatients of the Tartu University Hospital, admitted within 72 hours before enrolment. Exclusion Criteria: Age of \<18 years, inability or refusal to sign the consent form, pregnant or lactating women, more than 72 hours passed since admission, patients isolating with an infection.
Interventions
The patient is interviewed for changes in body weight in the last six months and food intake in the last two weeks. The investigator evaluates the patient's diet, symptoms related to their nutritional status, and functional capacity according to the Subjective Global Assessment (SGA). The SGA tool itself is completed by the researcher. Height and weight of the patient are measured, if not yet recorded, and BMI is calculated. The patient's muscle mass is measured using mid-upper arm circumference (MUAC), calf circumference (CC) and bioelectrical impedance (BIA), and their muscle function assessed using hand grip strength.
Eligibility Criteria
Inpatients of day patients admitted to the Tartu University Hospital.
You may qualify if:
- Age of 18+ years
- Able and willing to sign the consent form
- Inpatients of the Tartu University Hospital
- Admitted within 72 hours before enrolment
You may not qualify if:
- Age of \<18 years
- Inability or refusal to sign the consent form
- Pregnant or lactating women
- More than 72 hours passed since admission
- Patients isolating with an infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Tartulead
- Tartu University Hospitalcollaborator
Study Sites (1)
Tartu Ülikooli Kliinikum
Tartu, Tartu, 50406, Estonia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alastair Forbes, MD
University of Tartu, Tartu University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Visiting Professor
Study Record Dates
First Submitted
November 1, 2023
First Posted
December 11, 2023
Study Start
December 13, 2023
Primary Completion
March 31, 2025
Study Completion
June 30, 2025
Last Updated
March 28, 2025
Record last verified: 2025-02